United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Launch Of The Biotech And Biomanufacturing Hub

Earlier this year, the European Commission launched a Biotech and Biomanufacturing Hub that provides tools and resources to help companies, particularly start-ups and SMEs...

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

Covert medication means giving someone medicine without their knowledge or consent, usually by disguising it in food or drink, or by administering it through a tube.

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

The UK government has published its response to the recent consultation on the UK Medical Devices Regulations.

United Kingdom Healthcare

AP

Arnold & Porter

UK Proposes Early Access Service For Innovative Medical Devices

On 31 July 2025, the UK government published a statement of policy intent, setting out its initial thinking on an Early Access Service (EAS) for innovative medical devices.

United Kingdom Healthcare

AP

Arnold & Porter

EU Regulatory Reform For Medicinal Products: Bolar Exemption

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Watch What The Federal Government Does, Not What It Says, About Artificial Intelligence

United Kingdom Technology

IG

IR Global

Product Regulation And Metrology Bill Receives Royal Assent

United Kingdom Healthcare

JD

Jones Day

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Virtual And Digital Health Digest – July 2025

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

United Kingdom Healthcare

AP

Arnold & Porter

Life Science Sector Plans Issued

United Kingdom Healthcare

LS

Lewis Silkin

A New European Strategy To Foster Life Sciences Innovation And Market Access

European Union Healthcare

AO

A&O Shearman

Tackling The Source Of Phantom Limb Pain With Nerve Stimulation

United Kingdom IP

MC

Marks & Clerk

In Conversation With Kevin Nash: The LCIA And The Future Of Institutional Arbitration (Podcast)

United Kingdom Litigation

KL

Herbert Smith Freehills Kramer LLP

ThinkHouse TUPE Club: Key Questions On A Service Provision Change (Video)

United Kingdom Employment

GW

Gowling WLG

Hidden Homelessness: Legal Guidance For 'Sofa-Surfers' (29 July 2025) (Video)

United Kingdom Real Estate

DL

Duncan Lewis & Co Solicitors

UPCOMING WEBINAR: Online Safety: Navigating Compliance Across The UK, The EU And The US

Worldwide Compliance

HS

Herbert Smith Freehills Kramer LLP

Unlocking The Future Of Solar Energy In The UK (Podcast)

United Kingdom Energy

GW

Gowling WLG

The Case For Core Focus Among Mid-market Medical Device Companies

Mid-market medical device companies are grappling with underperformance, driven in part by over-diversified portfolios and fragmented management focus.

United Kingdom Healthcare

A

AlixPartners

Neurotech Patents In Europe: Part 2 - Novelty, Inventive Step, And Device-Specific Pitfalls

Building on my previous article relating neurotech to European patentability exclusions, I will discuss how the novelty of medical devices is assessed differently from pharmaceuticals.

United Kingdom IP

MC

Marks & Clerk

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

Globally, market volatility has eroded confidence and subdued M&A activity. A "wait and see" approach is the prevailing sentiment for many market participants...

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

In the latest of our articles about the UK government's industrial strategy and sector plans, we're now taking a look at its tech and digital sector plan.

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

Worldwide Healthcare

PC

Potter Clarkson

The Pioneers: Financial Times Interview With Michelle Mitchell

United Kingdom Healthcare

WL

Withers LLP

Supporting Growth – What Does The UK's Industrial Strategy Mean For Life Sciences?

United Kingdom Healthcare

GW

Gowling WLG

UK Government Issues New Industrial Strategy

United Kingdom Strategy

LS

Lewis Silkin

EU Medical Device Software: New Guidance On Placing Software Medical Devices On The EU Market

European Union Healthcare

AP

Arnold & Porter

Personalised Medicine And MedTech

United Kingdom Healthcare

LS

Lewis Silkin

UPC Delivers First Judgment On Validity And Infringement Of A Second Medical Use Claim

United Kingdom IP

HL

HGF Ltd

Looking To The Future - UK Biotech In 2035

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

European Union Healthcare

AP

Arnold & Porter

£13.9bn Of R&D Funding

United Kingdom Strategy

IG

IR Global

UPC Delivers First Judgment On Validity And Infringement Of A Second Medical Use Claim

The Dusseldorf Local Division (LD) has delivered the UPC's first Judgment on second medical use claims. The case concerns EP 3 536 712, exclusively licensed to Sanofi by Regeneron.

United Kingdom IP

HL

HGF Ltd

Looking To The Future - UK Biotech In 2035

The bioindustry association (BIA) have issued a new report setting out their vision for UK biotech in 2035. The headline approach is that there needs to be a "shift in mindset" to unlock the UK's full potential.

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies.

European Union Healthcare

AP

Arnold & Porter

£13.9bn Of R&D Funding

The UK government has announced a record-breaking £13.9 billion in research and development (R&D) funding for the coming year.

United Kingdom Strategy

IG

IR Global

The Effect Of The Unified Patent Court (UPC) On Opposition Proceedings At The European Patent Office (EPO)

United Kingdom IP

KL

Keltie LLP

Going Down The Bio-Produced Silk Road

I therefore read with interest an article published by the World Economic Forum (here) discussing how innovative materials made from man-made silk proteins...

United Kingdom IP

MC

Marks & Clerk

A New Approach To Regulation By The MHRA And NICE

On March 17, 2025, the government published a policy paper with an Action Plan for regulation and regulators, outlining how it intends to reform the UK's regulatory system to support growth and innovation.

United Kingdom Healthcare

AO

A&O Shearman

ABPI Calls For Changes To "Unsustainable" Medicines Pricing Scheme

The Association of the British Pharmaceutical Industry (ABPI) has published a report (the Report) setting out its members' concerns regarding...

United Kingdom Healthcare

AP

Arnold & Porter

Is Seaweed The New Wonder Product?

We have previously reported (here and here) on some of the innovative and diverse uses seaweed is being put to. I was therefore intrigued to read an article in the Guardian newspaper...

United Kingdom Healthcare

MC

Marks & Clerk

Will Labour's Policy Prescription Create A Stronger UK Life Sciences Sector?

United Kingdom Healthcare

AO

A&O Shearman

What To Know When Selling Your Pharmacy

United Kingdom Healthcare

RF

Ronald Fletcher Baker

EU Leads Global Charge As Abuse Of Dominance Cases Target Big Tech

Worldwide Anti-trust

AO

A&O Shearman

A Culture And Environment For Neurodiverse Teams

United Kingdom IP

MC

Marks & Clerk

Pharma TM Articles

United Kingdom Healthcare

R

Rouse

Can You Turn A Skin Cell Into Another Type Of Cell?

United Kingdom IP

MC

Marks & Clerk

UK ICO Announces Cookies Compliance Review Of The UK's Top 1,000 Websites

United Kingdom Privacy

AP

Arnold & Porter

Multidrug-Resistant Bacteria Discovered In Space

United Kingdom Healthcare

B

Boult Wade Tennant

X-Traordinary Ageing: Silent X Chromosome Awakens To Boost Female Brain

United Kingdom Healthcare

MC

Marks & Clerk

Patentability Of AI Inventions In Europe: Life Sciences, Chemical And Biotechnology Inventions

European Union IP

M

Murgitroyd

Online Pharmacies Required To Strengthen Safeguards To Prevent Unsafe Supply Of Medicines In The UK

United Kingdom Healthcare

AP

Arnold & Porter

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

How Will The Trump Administration Affect The UK Biotech Industry?

United Kingdom Healthcare

MC

Marks & Clerk

Proprietary Association Of Great Britain (PAGB) Updated Professional Code For Medicines

United Kingdom Healthcare

AP

Arnold & Porter

A Snapshot Into HLK's 175-year History

United Kingdom IP

H

HLK

See more

Latest Videos

See more

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

EU And UK Compliance Considerations In Remote Promotion Training And Medical Information Services (Video)

AP

Arnold & Porter

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

The International Advantage Of Using A UK Patent Attorney - Dehns And ConceptoMed

D

Dehns

Measuring The Return From Pharmaceutical Innovation 2012 (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More